These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14711450)

  • 1. Central serous chorioretinopathy and glucocorticoids.
    Cusani M
    Surv Ophthalmol; 2004; 49(1):128-9; author reply 129. PubMed ID: 14711450
    [No Abstract]   [Full Text] [Related]  

  • 2. Central serous chorioretinopathy and glucocorticoids.
    Bouzas EA; Karadimas P; Pournaras CJ
    Surv Ophthalmol; 2002; 47(5):431-48. PubMed ID: 12431693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central serous chorioretinopathy as a complication of epitheliopathy under treatment with glucocorticoids].
    Fernández Hortelano A; Sádaba LM; Heras Mulero H; García Layana A
    Arch Soc Esp Oftalmol; 2005 Apr; 80(4):255-8. PubMed ID: 15852168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central serous chorioretinopathy as a complication of postcardiac transplant corticosteroid therapy.
    Singh AD; Demirci H; Shields CL; Shields JA
    Eye (Lond); 2003 May; 17(4):522-4. PubMed ID: 12802354
    [No Abstract]   [Full Text] [Related]  

  • 5. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids.
    Bouzas EA; Moret P; Pournaras CJ
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):166-8. PubMed ID: 9987635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central serous chorioretinopathy.
    Jumper JM
    Br J Ophthalmol; 2003 Jun; 87(6):663. PubMed ID: 12770954
    [No Abstract]   [Full Text] [Related]  

  • 7. Central serous chorioretinopathy after local application of glucocorticoids for skin disorders.
    Karadimas P; Kapetanios A; Bouzas EA
    Arch Ophthalmol; 2004 May; 122(5):784-6. PubMed ID: 15136332
    [No Abstract]   [Full Text] [Related]  

  • 8. Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy.
    Levy J; Marcus M; Belfair N; Klemperer I; Lifshitz T
    Can J Ophthalmol; 2005 Apr; 40(2):217-21. PubMed ID: 16049541
    [No Abstract]   [Full Text] [Related]  

  • 9. Central serous chorioretinopathy associated with topical dermal corticosteroids.
    Fernandez CF; Mendoza AJ; Arevalo JF
    Retina; 2004 Jun; 24(3):471-4. PubMed ID: 15187679
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosomatic aspects in patients with central serous chorioretinopathy.
    Spahn C; Wiek J; Burger T; Hansen L
    Br J Ophthalmol; 2003 Jun; 87(6):704-8. PubMed ID: 12770965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serous chorioretinopathy complicating systemic corticosteroid therapy.
    Abu el-Asrar AM
    Eur J Ophthalmol; 1997; 7(3):297-300. PubMed ID: 9352287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid.
    Mondal LK; Sarkar K; Datta H; Chatterjee PR
    Indian J Ophthalmol; 2005 Jun; 53(2):132-4. PubMed ID: 15976473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
    Bevis T; Ratnakaram R; Smith MF; Bhatti MT
    Clin Exp Ophthalmol; 2005 Aug; 33(4):437-9. PubMed ID: 16033370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis.
    Baumal CR; Martidis A; Truong SN
    Arch Ophthalmol; 2004 Jun; 122(6):926-8. PubMed ID: 15197074
    [No Abstract]   [Full Text] [Related]  

  • 15. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
    Imasawa M; Ohshiro T; Gotoh T; Imai M; Iijima H
    Acta Ophthalmol Scand; 2005 Feb; 83(1):132-3. PubMed ID: 15715582
    [No Abstract]   [Full Text] [Related]  

  • 16. Central serous chorioretinopathy after epidural corticosteroid injection.
    Iida T; Spaide RF; Negrao SG; Carvalho CA; Yannuzzi LA
    Am J Ophthalmol; 2001 Sep; 132(3):423-5. PubMed ID: 11530067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis.
    Stuebiger N; Biester S; Deuter CM; Zierhut M
    Ocul Immunol Inflamm; 2008; 16(3):109-11. PubMed ID: 18569799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic central serous chorioretinopathy--a physical complication of stress?
    Wynn PA
    Occup Med (Lond); 2001 Mar; 51(2):139-40. PubMed ID: 11307690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study.
    Karadimas P; Bouzas EA
    Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):800-2. PubMed ID: 14986014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids.
    Hooymans JM
    Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):876-9. PubMed ID: 9825265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.